Showing results (51-60 of 124) with videos related to
Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
The biology of metastasis to a sanctuary siteDiane Palmieri, Ann F Chambers, Brunhilde Felding-Habermann, et al.BJU International|September 13, 2005
Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladderCelina Ang, Ann F Chambers, Alan B Tuck, et al.Magnetic Resonance in Medicine|October 10, 2006
In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brainChris Heyn, John A Ronald, Soha S Ramadan, et al.Nutrition and Cancer|December 21, 2006
In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extractPeter J Ferguson, Elzbieta M Kurowska, David J Freeman, et al.Cancer|September 5, 2002
Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinomaSebastien J Hotte, Eric W Winquist, Larry Stitt, et al.The Journal of Nutrition|June 3, 2004
A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell linesPeter J Ferguson, Elzbieta Kurowska, David J Freeman, et al.Cancer Genetics and Cytogenetics|September 13, 2008
Distinct karyotypes in three breast cancer cell lines --21PTCi, 21NTCi, and 21MT-1 --derived from the same patient and representing different stages of tumor progressionJie Xu, Lesley H Souter, Ann F Chambers, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 7, 2008
New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?Paul Goss, Alison L Allan, David I Rodenhiser, et al.Expert Opinion on Therapeutic Targets|July 21, 2018
Role of osteopontin as a predictive biomarker for anti-EGFR therapy in triple-negative breast cancerPieter H Anborgh, Danny J Lee, Pieter F Stam, et al.Journal of Molecular Medicine (Berlin, Germany)|April 7, 2016
Primary melanoma tumor inhibits metastasis through alterations in systemic hemostasisJennifer M Kirstein, M Nicole Hague, Patricia M McGowan, et al.Pageof 13